FTI CONSULTING, INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FTI CONSULTING, INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.79B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.70B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.49B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.03B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.78B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $626.58M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $622.25M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $607.85M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $604.59M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $602.22M | Feb 25, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.79B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.70B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.49B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.03B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.78B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $2.46B | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $602.22M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $593.11M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $606.12M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $551.27M | Feb 25, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.22B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.18B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.14B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $962.93M | Feb 20, 2025 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $270.87M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $280.09M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $274.89M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $235.51M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $234.97M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $55.59M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $50.17M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $48.17M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $56.75M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $29.06M | Feb 25, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $389.08M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $347.36M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $377.56M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $303.88M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $312.05M | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $70.94M | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | $73.07M | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | $65.60M | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | $73.06M | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | $48.20M | Feb 25, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $799.62M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $822.15M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $751.31M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $641.07M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $537.84M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $488.41M | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $133.03M | Feb 25, 2020 |
| FY2019 | Sep 30, 2019 | $127.95M | Feb 25, 2020 |
| FY2019 | Jun 30, 2019 | $129.91M | Feb 25, 2020 |
| FY2019 | Mar 31, 2019 | $113.19M | Feb 25, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $152.13M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $395.10M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $224.46M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $188.79M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $355.48M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $327.07M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $217.89M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $230.67M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $147.63M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $233.49M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $58.53M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $35.41M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $49.48M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $53.32M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $68.67M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $34.85M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $41.82M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $32.27M | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $32.00M | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $28.94M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.49B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.60B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $3.33B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $3.24B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.10B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.78B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $2.78B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $2.38B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $2.26B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $2.23B | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.34B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $1.34B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.56B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.52B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.38B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.29B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.03B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $1.07B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $1.02B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.73B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.26B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.98B | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $1.68B | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $1.58B | Feb 20, 2025 |
| FY2023 | Dec 31, 2020 | $1.40B | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $1.49B | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $1.35B | Feb 24, 2022 |
| FY2020 | Dec 31, 2017 | $1.19B | Feb 25, 2021 |
| FY2019 | Dec 31, 2016 | $1.21B | Feb 25, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.24B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.23B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.23B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.23B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.23B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.23B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $1.20B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.17B | Feb 25, 2021 |
| FY2019 | Dec 31, 2017 | $1.20B | Feb 25, 2020 |
| FY2018 | Dec 31, 2016 | $1.18B | Feb 27, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.86B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.39B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.11B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $1.86B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.70B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.51B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $1.41B | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $1.20B | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $1.05B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $941.00M | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $265.09M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $660.49M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $303.22M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $491.69M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $494.49M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $294.95M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $369.37M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $312.07M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $189.96M | Feb 27, 2019 |
| FY2018 | Dec 31, 2016 | $216.16M | Feb 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2024 | $0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $0 | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $315.17M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $297.16M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $286.13M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $275.61M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | $265.57M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | $396.28M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $365.53M | Feb 22, 2018 |
| FY2015 | Dec 31, 2015 | $500.00M | Feb 25, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 25, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 7 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Mar 31, 2020 | 1 | Feb 25, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 25, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 30.86M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 35.91M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 35.52M | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | 34.03M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 34.33M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 34.48M | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | 37.39M | Feb 25, 2021 |
| FY2019 | Dec 31, 2018 | 38.15M | Feb 25, 2020 |
| FY2018 | Dec 31, 2017 | 37.73M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 42.04M | Feb 22, 2018 |